Biomarker
Non-HDL Cholesterol
Last updated Sat May 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Observational— Better than LDL-C alone, weaker than apoB
What it measures
Non-HDL cholesterol = total cholesterol − HDL-C. It captures the cholesterol in all atherogenic particles (LDL + IDL + VLDL + remnants), not just LDL. Because it doesn’t depend on the Friedewald calculation, it remains accurate when triglycerides are elevated.
When to use it
- When apoB testing isn’t available, non-HDL is the next-best proxy.
- When LDL-C is unreliable (high triglycerides, post-meal sample).
- In children and adolescents where non-HDL may be more stable than LDL-C.
Targets
Generally LDL-C target + 30 mg/dL:
- Primary prevention: <130 mg/dL.
- Diabetes / multiple risk factors: <100 mg/dL.
- Established ASCVD: <85 mg/dL.
Limitations
Non-HDL still measures cholesterol mass, not particle count. Same discordance with apoB exists when small dense LDL predominates — just less than with LDL-C.
Related entries
References
- Sniderman, A. D. et al. Non-HDL cholesterol versus apolipoprotein B in cardiovascular risk stratification. JAMA 309, 2103–2110 (2013).